Association of GSTP1 Ile105Val polymorphism with the risk of coronary heart disease: An updated meta-analysis.

<h4>Background</h4>Numerous case-control studies have investigated the association between GSTP1 Ile105Val polymorphism and CHD risk, but the results from published studies were inconclusive. The present meta-analysis was performed to derive a more precise estimation.<h4>Methods<...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yadong Song, Xiaoli Liu, Cheng Luo, Liangkai Chen, Lin Gong, Hanbin Yu, Bin Wang, Ernan Liu, Huiqiong Xu, Jiansheng Liang
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1c838f3a9ce044fb8715189c321fe759
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1c838f3a9ce044fb8715189c321fe759
record_format dspace
spelling oai:doaj.org-article:1c838f3a9ce044fb8715189c321fe7592021-12-02T20:06:38ZAssociation of GSTP1 Ile105Val polymorphism with the risk of coronary heart disease: An updated meta-analysis.1932-620310.1371/journal.pone.0254738https://doaj.org/article/1c838f3a9ce044fb8715189c321fe7592021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0254738https://doaj.org/toc/1932-6203<h4>Background</h4>Numerous case-control studies have investigated the association between GSTP1 Ile105Val polymorphism and CHD risk, but the results from published studies were inconclusive. The present meta-analysis was performed to derive a more precise estimation.<h4>Methods</h4>PubMed, EMBASE, and Web of Science database searches were conducted to retrieve relevant articles.<h4>Results</h4>Ultimately, 5,451 CHD cases and 5,561 controls from 15 studies were included. Pooled analysis did not yield any statistically significant association between GSTP1 Ile105Val polymorphism and CHD risk for the overall population (Val vs. Ile: OR, 1.05; 95% CI, 0.93 to 1.18; Val/Val vs. Ile/Ile: OR, 1.09; 95% CI, 0.83 to 1.42; Val/Ile vs. Ile/Ile: OR, 1.09; 95% CI, 0.93 to 1.28; Val/Val vs. Val/Ile+Ile/Ile: OR, 1.04; 95% CI, 0.83 to 1.30; Val/Val+Val/Ile vs. Ile/Ile: OR, 1.14; 95% CI, 0.97 to 1.33). Subgroup analyses and sensitivity analyses indicated that GSTP1 Ile105Val polymorphism was still not associated with an increased risk of CHD. After excluding studies detected by Galbraith plots as major sources of heterogeneity, these relationships were still not significant.<h4>Conclusions</h4>The overall results did not reveal a major role of the GSTP1 Ile105Val polymorphism in modulating CHD risk. Well-designed studies with large sample sizes are needed to validate our findings and explore the possible gene-gene or gene-environment interactions.Yadong SongXiaoli LiuCheng LuoLiangkai ChenLin GongHanbin YuBin WangErnan LiuHuiqiong XuJiansheng LiangPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0254738 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yadong Song
Xiaoli Liu
Cheng Luo
Liangkai Chen
Lin Gong
Hanbin Yu
Bin Wang
Ernan Liu
Huiqiong Xu
Jiansheng Liang
Association of GSTP1 Ile105Val polymorphism with the risk of coronary heart disease: An updated meta-analysis.
description <h4>Background</h4>Numerous case-control studies have investigated the association between GSTP1 Ile105Val polymorphism and CHD risk, but the results from published studies were inconclusive. The present meta-analysis was performed to derive a more precise estimation.<h4>Methods</h4>PubMed, EMBASE, and Web of Science database searches were conducted to retrieve relevant articles.<h4>Results</h4>Ultimately, 5,451 CHD cases and 5,561 controls from 15 studies were included. Pooled analysis did not yield any statistically significant association between GSTP1 Ile105Val polymorphism and CHD risk for the overall population (Val vs. Ile: OR, 1.05; 95% CI, 0.93 to 1.18; Val/Val vs. Ile/Ile: OR, 1.09; 95% CI, 0.83 to 1.42; Val/Ile vs. Ile/Ile: OR, 1.09; 95% CI, 0.93 to 1.28; Val/Val vs. Val/Ile+Ile/Ile: OR, 1.04; 95% CI, 0.83 to 1.30; Val/Val+Val/Ile vs. Ile/Ile: OR, 1.14; 95% CI, 0.97 to 1.33). Subgroup analyses and sensitivity analyses indicated that GSTP1 Ile105Val polymorphism was still not associated with an increased risk of CHD. After excluding studies detected by Galbraith plots as major sources of heterogeneity, these relationships were still not significant.<h4>Conclusions</h4>The overall results did not reveal a major role of the GSTP1 Ile105Val polymorphism in modulating CHD risk. Well-designed studies with large sample sizes are needed to validate our findings and explore the possible gene-gene or gene-environment interactions.
format article
author Yadong Song
Xiaoli Liu
Cheng Luo
Liangkai Chen
Lin Gong
Hanbin Yu
Bin Wang
Ernan Liu
Huiqiong Xu
Jiansheng Liang
author_facet Yadong Song
Xiaoli Liu
Cheng Luo
Liangkai Chen
Lin Gong
Hanbin Yu
Bin Wang
Ernan Liu
Huiqiong Xu
Jiansheng Liang
author_sort Yadong Song
title Association of GSTP1 Ile105Val polymorphism with the risk of coronary heart disease: An updated meta-analysis.
title_short Association of GSTP1 Ile105Val polymorphism with the risk of coronary heart disease: An updated meta-analysis.
title_full Association of GSTP1 Ile105Val polymorphism with the risk of coronary heart disease: An updated meta-analysis.
title_fullStr Association of GSTP1 Ile105Val polymorphism with the risk of coronary heart disease: An updated meta-analysis.
title_full_unstemmed Association of GSTP1 Ile105Val polymorphism with the risk of coronary heart disease: An updated meta-analysis.
title_sort association of gstp1 ile105val polymorphism with the risk of coronary heart disease: an updated meta-analysis.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/1c838f3a9ce044fb8715189c321fe759
work_keys_str_mv AT yadongsong associationofgstp1ile105valpolymorphismwiththeriskofcoronaryheartdiseaseanupdatedmetaanalysis
AT xiaoliliu associationofgstp1ile105valpolymorphismwiththeriskofcoronaryheartdiseaseanupdatedmetaanalysis
AT chengluo associationofgstp1ile105valpolymorphismwiththeriskofcoronaryheartdiseaseanupdatedmetaanalysis
AT liangkaichen associationofgstp1ile105valpolymorphismwiththeriskofcoronaryheartdiseaseanupdatedmetaanalysis
AT lingong associationofgstp1ile105valpolymorphismwiththeriskofcoronaryheartdiseaseanupdatedmetaanalysis
AT hanbinyu associationofgstp1ile105valpolymorphismwiththeriskofcoronaryheartdiseaseanupdatedmetaanalysis
AT binwang associationofgstp1ile105valpolymorphismwiththeriskofcoronaryheartdiseaseanupdatedmetaanalysis
AT ernanliu associationofgstp1ile105valpolymorphismwiththeriskofcoronaryheartdiseaseanupdatedmetaanalysis
AT huiqiongxu associationofgstp1ile105valpolymorphismwiththeriskofcoronaryheartdiseaseanupdatedmetaanalysis
AT jianshengliang associationofgstp1ile105valpolymorphismwiththeriskofcoronaryheartdiseaseanupdatedmetaanalysis
_version_ 1718375348489420800